|
|
||||||||



* Agriculture and Agri-Food Canada, Lennoxville, QC, Canada J1M 1Z3
Département des sciences animales, Université Laval, Ste-Foy, QC, Canada G1K 7P4
Nittany Dairy Nutrition, Mifflinburg, PA 17844
Faculté de Médecine Vétérinaire, Université de Montréal, St-Hyacinthe, QC, Canada JZ5 3B7
|| Degussa Canada Ltd., Burlington, ON, Canada L7R 3Y8
¶ University of Guelph, Guelph, ON, Canada NIG 2W1
2 Corresponding author: berthiaumer{at}agr.gc.ca
| ABSTRACT |
|---|
|
|
|---|
Key Words: methionine amino acid dairy cow splanchnic
| INTRODUCTION |
|---|
|
|
|---|
In series with the portal-drained viscera (PDV), the liver is the first organ to see newly absorbed AA and is a major site of catabolism for some essential AA, namely Met, His, Phe, and Thr (Lapierre et al., 2005). It is not clear, however, if this role is active or passive (Lobley and Lapierre, 2003), but it is clear that liver removal of AA is directly linked to total hepatic influx (Hanigan et al., 2004a). In early lactation dairy cows, hepatic removal of Met was shown to be substantial, varying between 30 and 40% of net portal absorption (Bach et al., 2000). In this study, fractional extraction rate of Met was not affected by the AA profile of dietary protein nor by the level of CP, despite a significant increase (51%) in net portal absorption. In contrast, Raggio et al. (2004) showed recently that hepatic removal of Met relative to net portal absorption linearly increased with increasing MP supply, going from 28% in the low MP diet to 44% in the high MP diet.
Unfortunately, none of these studies has investigated the behavior of hepatic extraction of AA in lactating dairy cows when the supply of a single AA is increased. Because Met is considered as one of the most limiting AA in many North American dairy cow diets, a trial was designed to establish the impact of using ruminally protected Met (RPM) to increase the supply of absorbable Met on portal delivery, hepatic removal, and mammary uptake of AA in relation with milk protein output in lactating dairy cows.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
|
|
Sampling Procedure
Experimental periods lasted 14 d. Feed samples were taken daily and composited for each period. On d 14 of each period, 6 hourly blood samples (17 mL each) were simultaneously collected from the artery, and the portal, hepatic and mammary veins, starting at 0830 h. Additional samples of arterial, portal, hepatic, and mammary blood (2 mL) were collected into a blood-gas collection device (Monovette, Sarstedt, Aktiegesellschaft and Co., Germany) for the determination of pH and concentrations of O2 and CO2. Blood flow in the portal and hepatic vein was determined by downstream dilution of pAH (10% wt/vol) infused continuously (144 mL/h) into one distal mesenteric vein catheter. This followed a priming dose of 20 mL started at least 40 min before the first sample collection. Immediately after collection, aprotinin (500 trypsin inhibitor units/mL) was added to a 2-mL aliquot of blood for glucagon analysis. Blood samples were kept on ice until processed (usually within 1 h).
Laboratory Analysis
Samples of feed were lyophilized and ground to pass a 1-mm screen. Subsamples of feed were ashed at 550°C for 12 h in a muffle furnace. Feed N was determined by micro-Kjeldahl analysis (AOAC, 1996) and N in milk was determined by thermal conductivity (Leco model FP-428 Nitrogen Determinator, Leco, St. Joseph, MI). Crude protein contents of feed and milk were calculated as N x 6.25 and N x 6.38, respectively. Noncasein N and NPN in milk were analyzed with the micro-Kjeldahl method. Noncasein N was obtained by precipitation of the caseins at pH 4.6. Nonprotein N was obtained by precipitation with TCA, at a final concentration of 12%. Casein N was calculated by the difference between total N and noncasein N, and whey protein was estimated by difference between noncasein N and NPN. Milk fat was measured according to the Röse-Gottlieb method (AOAC, 1996). Milk samples were analyzed for DM and OM with a thermogravimetric analyzer (Model TGA 601, Leco) and milk lactose was determined by difference (DM Ash CP Fat). Fiber fractions (NDF, ADF, and lignin), ADIN, and neutral detergent insoluble N were determined on feed samples according to Van Soest et al. (1991). Feeds were analyzed for pH, soluble N, and NPN according to Krishnamoorthy et al. (1983). For AA determination, samples of feed were predigested with performic acid to stabilize Met and Cys, treated with hydrobromic acid to destroy the performic acid, and then acid-hydrolyzed with 6 N HCl (method # 994-12; AOAC, 1996). A separate acid hydrolysis (6 N HCl) digestion procedure was conducted for Phe, Tyr, and His, because those AA are destroyed during the oxidation process and by reaction with bromine. Concentrations of AA were quantified by ion exchange chromatography (Beckmann 6300, Beckmann Instruments, Palo Alto, Ca).
Measurements of blood packed-cell volume, partial pressure of O2 and CO2, and pH were obtained immediately after collection using a blood gas analyzer (Model IL 1306, Instrumentation Laboratory, Lexington, MA). The packed cell volume of each blood sample was determined by the microhematocrit method (Strumia et al., 1954). Hemoglobin was determined colorimetrically using cyanmethemoglobin as the standard. Concentrations of blood urea, pAH, ammonia-N and
-amino-N, and plasma pAH were determined using the Technicon AutoAnalyzer on the day of sampling except for plasma pAH, which was frozen and analyzed later (Huntington, 1984). The ammonia-N concentrations were corrected for an
-amino-N reaction in the ammonia assay, using the relative response of a leucine standard and measured
-amino-N concentrations (Broderick and Kang, 1980). An enzymatic method (Kit #166391, Boehringer Mannheim, Dorval, QC, Canada) was used to determine plasma glucose. For glucagon analysis, samples with aprotinin were centrifuged at 2,100 x g for 12 min and plasma samples were kept frozen until analyzed. Plasma hormone concentrations were determined using double-antibody radioimmunoassay as described by Lapierre et al. (1992) for insulin and by Herbein et al. (1985) for glucagon (30 K antibodies, Univ. Texas, Southwestern Medical School, Dallas, TX). Inter- and intraassay coefficients of variation for insulin were 6.6 and 13.2%, and for glucagon were 9.1, and 6.4%, respectively. Blood AA were determined by two methods. The essential AA His, Ile, Leu, Lys, Met, Phe, Thr, and Val, and two nonessential AACys, which is involved in the metabolism of Met, and Tyr, which was used to estimate mammary blood flow according to the Fick principlewere analyzed on whole blood by isotopic dilution (Calder et al., 1999). This technique was chosen because results are less variable than results obtained with AA analyzers. For this method, 1.5 mL of an internal standard solution of AA was added to 1.5 mL of whole blood and immediately frozen until analyzed by isotopic dilution with a gas chromatograph coupled to a mass spectrometer (GC-MS, Hewlett Packard, Houston, TX; GC: model HP6890; MS: S973). The internal standard solution was prepared with labeled AA diluted in 0.1 N HCl to give the following concentration (µM): L-Cys-15N (40), DL-His-
-15N (34.6), L-Ile-15N (142.6), L-Leu-1-13C (175.4), DL-Lys-2-15N-2HCl (67.1), DL-Met-1-13C (19.6), L-Phe-1-13C (45.1), L-Thr-15N (9.1), L-Tyr-15N (53.1), and L-Val-15N (169.2). The labeled AA, His, Leu, Lys, Met, and Phe (95 to 99 atom %) were supplied by CDN Isotopes (Pointe-Claire, QC, Canada); Cys, Ile, Thr, and Tyr by Cambridge Isotope Laboratories (Andover, MA), and Val by Isotec, Inc. (Miamisburg, OH). Analysis was performed on each of the 6 hourly samples.
All AA were also determined in plasma. For this method, the 6 hourly samples were pooled for every 2-h sampling period into 3 pooled samples. Then, 200 mg of a dithiothreitol (5 mM)norleucine (1 mM) solution was added to 1 g of plasma and vortexed. This mixture was deproteinized by adding 150 µL of sulfosalicylic acid (48%), and then centrifuged at 16,610 x g for 12 min. The supernatant was decanted and centrifuged as described above. The pH of the filtrate was adjusted to 2.0 to 2.5 with 20 to 50 µL of NaOH (10%) and kept frozen. Samples were analyzed for individual free AA using an amino acid analyzer (Pharmacia Alpha Plus II; Amersham Pharmacia Biotech, Little Chalfont, UK). Due to technical problems with His analyses on whole blood samples, plasma values are reported. Therefore, reported concentrations of Ile, Leu, Lys, Met, Phe, Thr, Val, Cys, and Tyr were based on whole blood samples (n = 6 per day of sampling) and concentrations of other AA reported were based on plasma samples (n = 3 per day of sampling).
Calculations and Statistical Analyses
Blood and plasma flows in the portal and hepatic veins were measured by dilution of pAH (Katz and Bergman, 1969). Within one sampling day, if the CV of the mean plasma flow for an animal was greater than 15% due to only one sample, this value was removed. Milk protein output was estimated using milk protein yield and the AA composition of milk protein reported by Swaisgood (1995). Mammary plasma flow was estimated according to the Fick principle, using Phe and Tyr as internal markers (Mepham, 1982), with allowance for a 3.5% contribution from blood-borne proteins {mammary plasma flow = [(milk Phe + Tyr) x 0.965/(arterial-venous difference of Phe + Tyr)]} (Cant et al., 1993). Concentrations of O2 in blood were calculated using measured partial pressures of O2, pH, and hemoglobin concentrations according to Bartels and Harms (1959), whereas concentrations of CO2 in plasma were calculated using partial pressure of CO2 and pH (Oddy et al., 1984). Daily net fluxes were calculated as the product of blood or plasma flow and blood or plasma venous-arterial (VA) difference for the PDV, liver, the whole splanchnic bed (TSP), and the mammary glands (MG). Negative fluxes denote a net removal of a metabolite or hormone by the tissue whereas positive fluxes denote a net release from the tissue. Essential amino acids (EAA) evaluated were His, Ile, Leu, Lys, Met, Phe, Thr, and Val; nonessential amino acids (NEAA) were Ala, Arg, Asn, Asp, Cys, Glu, Gly, Pro, Ser, and Tyr; and branched-chain amino acids (BCAA) were Ile, Leu, and Val. Total amino acids were the sum of EAA and NEAA.
The VA differences (hepatic vein arterial, portal vein arterial, hepatic vein portal vein, and mammary vein arterial) were tested for difference from zero using the Students t-test. Daily means of arterial concentrations, VA differences, and net fluxes were calculated for each cow in each experimental period. All data were analyzed according to a replicated Latin square design balanced for residual effects using the Mixed procedure of SAS (SAS Institute, 2000), with square, cow (square), period, treatment, and the interaction parity by treatment all as fixed effects. The linear and quadratic effects of treatment were tested with polynomial contrasts (Gill, 1978). Treatment differences were considered significant if P < 0.10 unless otherwise stated.
Initial inspection of the milk composition data revealed that, there was an interaction (P < 0.05) between parity and treatment. Also, the same interaction was found for arterial concentrations of taurine (Tau) and net hepatic fluxes of Glu, Gly, and Val. There is inherent variation to be considered in this study associated with the measurement of net fluxes, the very large number of metabolites analyzed, and the associated probability of "detecting" significance when there was in fact none (Type 2 error). Therefore, it was decided to analyze and report the milk production and blood flow data for each parity group separately, noting the limited number of cases where there was a significant interaction on blood metabolites. Except for milk production and composition data, analyzing data separately had no effect on the biological interpretation.
| RESULTS |
|---|
|
|
|---|
Milk Production and Composition
As previously discussed, milk production and composition, and blood and plasma flow data were analyzed and reported separately for primiparous and multiparous cows because of a significant interaction between parity and treatment. Graded levels of RPM had no effect on DMI and milk production (Tables 4
and 5
). However, in primiparous cows (Table 4
), milk CP percentage (P = 0.04), true N percentage (P = 0.05), and casein N percentage (P = 0.07) increased linearly with increasing levels of RPM. Conversely, in multiparous cows (Table 5
), RPM had no effect on milk composition. Blood and plasma flows through the PDV and MG were unaffected by treatments (Table 6
). However, for TSP blood and plasma flows, an interaction (P < 0.05) existed between the parity and the treatments. Ruminally protected Met caused a linear increase in blood (P = 0.09) and plasma flow (P = 0.07) across the TSP in the multiparous cows, but not in primiparous cows.
|
|
|
|
Net fluxes of individual AA across the PDV, liver, TSP, MG, and in milk are presented in Table 8
. The addition of RPM to the diet linearly increased PDV flux of Met (P = 0.10) and Gly (P = 0.08). The PDV net fluxes of Glu (P = 0.09) responded quadratically to RPM supplementation, being highest for the 36 g/d level of intake. Hepatic removal of Arg (P = 0.10) and liver release of Val (P = 0.07) were affected quadratically by RPM. Liver removal of Asn (P = 0.03) linearly increased with the addition of RPM. Addition of RPM had both a linear (P = 0.03) and quadratic (P = 0.06) effect on the net hepatic flux of Gly. Net fluxes across the TSP of Ala, Ile, Leu, Phe, Thr, and Tyr (P < 0.10) all increased linearly with increasing RPM. Additionally there was a strong quadratic effect on Thr (P < .001) with the 36 g/d level showing the lowest TSP release. The net TSP flux of Asp (P = 0.006) responded in a quadratic fashion similar to Thr. Across the MG, RPM caused a linear increase in the uptake of His (P = 0.08) and a quadratic response in the uptake of Asp, Ile, Leu, and Val (P
0.09). For the latter 4 AA, the response was always a higher uptake for the 36 g/d compared with control and 72 g/d levels. The RPM had both a linear (P = 0.002) and quadratic (P = 0.05) effect on mammary uptake of Ala and Glu. Extraction of Ala was increased on 72 g/d but was unaffected by the 36 g/d of RPM; Glu uptake, on the other hand, was highest at 36 g/d and lowest at 72 g/d.
|
|
| DISCUSSION |
|---|
|
|
|---|
Blood Flow
Blood pH, hemoglobin, and packed-cell volume were in the normal range for lactating dairy cows and were not affected by RPM. The significant interaction between parity and treatment on TSP flows remains unexplained but could merely be due to the difference in DMI (15 vs. 19 kg/d) observed between primiparous and multiparous cows. Average portal (1,420 L/h), splanchnic (1,693 L/h), and mammary (697 L/h) plasma flows observed in this study are in the range reported in recent studies with lactating dairy cows in different stages of lactation and fed different diets (Bach et al., 2000; Benson et al., 2002; Blouin et al., 2002; Reynolds et al., 2003; Raggio et al., 2004). In these reports, portal plasma flows ranged from 1,193 to 1,807 L/h and splanchnic flows from 1,419 to 2,272 L/h. Moreover, portal blood flow made up 84% of splanchnic blood flow, which is in close agreement with the above studies. In the case of mammary plasma flow, our data are in good agreement with that of other groups using the Fick principle with Phe and Tyr as marker AA. A review of recently published data (Vanhatalo et al., 1999; Varvikko et al., 1999; Bach et al., 2000; Korhonen et al., 2000, 2002; Raggio et al., 2004;) estimated mammary plasma flow to range from 434 to 937 L/h, with milk production varying from 23 to 48 kg/d.
Amino Acids
Supplementation with RPM caused an elevation in arterial concentration of Met. This is in agreement with a previous trial in this laboratory (Berthiaume et al., 2001) and in previously published studies in which Met was ruminally protected (Overton et al., 1996, 1998; Blum et al., 1999) or infused postruminally (Guinard and Rulquin, 1995; Pisulewski et al., 1996; Varvikko et al., 1999). Using lactating dairy cows with rumen and intestinal cannulas, Berthiaume et al. (2001) showed that 73% of RPM bypassed the rumen, that at least 80% of this Met disappeared from the small intestine, and that 69% of Met absorbed in the mesenteric vein was recovered in the portal vein. Therefore, the 2 levels of RPM fed in the present trial would correspond to postruminal supplies of 22 and 44 g/d respectively, and should have increased the amount of Met disappearing from the small intestine by 18 and 35 g/d, and the PDV flux of Met by 12 and 24 g/d. However, RPM supplementation increased measured net PDV fluxes of Met by 2.5 and 9.3 g/d, which amount to 20 and 38% of expected increments. Reasons for such a low recovery of extra Met remain unclear; however, increased oxidation of AA across the PDV has been shown to be related to total supplyarterial plus absorption (Hanigan et al., 2004b). In our study, both arterial and luminal supplies increased with RPM supplementation, which could have resulted in a higher oxidation rate of Met across the PDV, and thus, underestimation of the availability of Met from RPM.
It has been suggested recently that hepatic removal of AA was closely associated with total hepatic influx, both in late lactation and in nonlactating dairy cows (Lobley and Lapierre, 2003; Hanigan et al., 2004a). Such an association was not observed in the current study, despite the fact that arterial and portal concentrations of Met largely increased, thereby increasing total hepatic influx of Met by 47%, from 0 to 72 g/d RPM. However, in the studies mentioned earlier (Lobley and Lapierre, 2003; Hanigan et al., 2004a), Met was not the only AA provided. Rather, the total supply of protein was increased by manipulating the diet or through the infusion of AA mixtures, causing an increase in the plasma concentrations of all AA. Perhaps an increase in the concentration of all AA is required to significantly alter hepatic removal of AA. However, studies in which only an analog of Met (2-hydroxy-4-[methylthio]-butanoic acid) was infused intravascularly, and only a higher concentration of the L-form of Met was induced (Lobley et al., 2001), hepatic removal of Met almost doubled from 8 to 15 mmol/h. This would indicate that the liver is able to react to changes in the supply of a single AA, contrary to what was observed in the present study. A possible explanation for this apparent contradiction is that this close relationship between hepatic influx and hepatic removal of AA is observed only when the increment in Met concentration is under the L-form. Because RPM is an equimolar mixture of the D and L forms, the plasma of RPM-fed cows will contain both the D and L forms (Lobley et al., 2001). The 2 isomers are metabolized differently and therefore may behave differently across the liver.
Overall, the addition of RPM resulted in a numerical, although statistically nonsignificant, increase of the amount of Met delivered to the peripheral tissues (net TSP fluxes) as was shown by others (Bach et al., 2000).
Whole blood Cys and plasma Tau concentrations were also increased by the addition of RPM in agreement with reported data using the same source (Overton et al., 1998) or other sources (Blum et al., 1999) of RPM. Cysteine concentrations reported in this study are higher than usually reported in the literature (Guinard and Rulquin, 1995; Mackle et al., 2000). This may reflect analytical problems associated with Cys determination (Lee et al., 1993). C. Girard and H. Lapierre (Dairy and Swine Research Centre, Lennoxville, QC, Canada, personal communication), using special conditions outlined by Malinow et al. (1989), measured Cys by HPLC in the plasma of lactating dairy cows supplemented with RPM. They observed levels of Cys similar to those measured in whole blood in the present trial.
We observed a linear decrease in whole blood concentrations of Phe, Leu, and Val. Other studies have shown that RPM causes a decrease in plasma levels of Phe (Overton et al., 1996), His (Guinard and Rulquin, 1995), and BCAA (Guinard and Rulquin, 1995; Blum et al., 1999). Results from a previous trial in this laboratory (Berthiaume et al., 2001) showed that the addition of 72 g/d of RPM to the diet of midlactation dairy cows elicited a significant decrease in circulating levels of Lys, Phe, Thr, and Val. Therefore, concentrations of BCAA and Phe appear to be consistently decreased with RPM supplementation. Interestingly, in this experiment, the postliver supply of the BCAA, Phe, Tyr, and Thr increased with the addition of RPM. This was unexpected and remains unexplained, although the possible interaction in the metabolism of Met and BCAA through Met transamination pathway has already been demonstrated (Benevenga, 1984). It is particularly interesting to note that following the addition of RPM, circulating concentrations of Met increased although net TSP fluxes of Met were unchanged while circulating concentrations of BCAA and Phe decreased despite an increase of the net TSP fluxes of those EAA. This suggests that RPM triggered a homeorhetic response that may have been mediated through MG in the case of the BCAA, as indicated by the elevation of BCAA uptake by MG, and through other tissues (e.g., muscle) in the case of Phe. The circulating levels of other EAA were similar to those reported in the literature (Overton et al., 1996; Pisulewski et al., 1996; Vanhatalo et al., 1999) and were not affected by the addition of RPM to the diet. In the case of NEAA, the addition of RPM had a quadratic effect on the circulating concentrations of Ala, Asn, Gln, and Ser. In all cases, concentrations decreased with the addition of 36 g/d of RPM and returned to the control level with the addition of 72 g/d of RPM. This suggests that as the diet went from a deficit (control) to adequate (36 g/d of RPM) and excessive (72 g/d of RPM) Met levels, those 4 AA were used as carbon and nitrogen shuttles, with the body trying to maintain lactation (homeorhesis) while avoiding Met toxicity (homeostasis).
Data presenting PDV, liver, TSP, and MG fluxes of individual AA in lactating dairy cows are very limited, thus explaining our interest in investigating interorgan fluxes. With the exception of Met, Glu, and Gly, net PDV fluxes of individual AA were unaffected by RPM. However, the liver metabolized individual AA to varying degrees. In the case of EAA, we observed no net release or uptake of BCAA and Lys, whereas Met (26% of PDV flux) and Phe (50% of PDV flux) were the 2 EAA removed in the largest amount by the liver of cows fed the control diet. The addition of RPM had no effect on Met or other sulfur AA subsequent to absorption, except for an unexpected linear decrease in TSP fluxes of Tau, a product of Met catabolism. However, hepatic-arterial differences for Tau were not different from zero. Although RPM had no effect on the net liver flux or on fractional hepatic extraction of other EAA, net TSP fluxes of the BCAA, Phe, and Thr were all increased with the addition of 72 g/d of RPM. To our knowledge this phenomenon has never been reported, and deserves more research.
In the present study, as reported with sheep (Milano et al., 2000) and beef cattle (Lapierre et al., 2000), liver uptake relative to portal release of NEAA was considerably higher than for EAA. Addition of RPM caused a linear increase in liver extraction of Asn and Gly and a linear increase in net TSP fluxes of Ala and Tyr. As determined previously (Bach et al., 2000) with lactating dairy cows, Gly, Ala, and Ser were the 3 AA removed in the greatest quantity by the liver. The fact that these 3 AA are glucogenic and that Gly is involved in the synthesis of bile acids and hippurate could explain why the net TSP flux of Gly was negative. Negative TSP fluxes of Gly have been reported previously with high-producing dairy cows (Bach et al., 2000). The linear increase in TSP flux of Ala is consistent with the absence of an effect of RPM on gluconeogenesis.
The addition of RPM did affect mammary extraction of Met, which decreased linearly from 38.4 to 27.1%, as observed by others following intragastric infusions of DL-Met (Guinard and Rulquin, 1995; Varvikko et al., 1999). However, the addition of RPM also provoked a linear increase in mammary extraction of the BCAA, His, Phe, and Tyr. This phenomenon was not observed by others, which may be due to the possibility that Lys was deficient in this study and that cows were probably in negative energy balance (Table 1
). This data set also allowed us to study the relationship between net TSP fluxes of EAA and milk protein and EAA output. In the control, EAA from group 1 as defined by Fleet and Mepham (1985) were more efficiently captured by the mammary gland and transferred to milk (ratio of milk/TSP: His = 0.81, Met = 0.85, and Phe = 0.92) than group 2 AA, (Ile = 0.57, Leu = 0.52, = Lys = 0.61, Thr = 0.73, and Val = 0.54). This is in agreement with a major catabolism of Met, His, and Phe in the liver (Lapierre et al., 2005).
Metabolites and Hormones
Nitrogenous Compounds.
Arterial or net splanchnic fluxes of ammonia-N and urea-N were not affected by RPM. Arterial concentrations of ammonia-N were similar to those reported by Huntington (1984) and Reynolds et al. (1988) with lactating dairy cows but urea-N concentrations were higher than those reported in previous studies from this laboratory (Berthiaume et al., 2001; Blouin et al., 2002; Raggio et al., 2004). This may be reflective of differences in diet composition and metabolic status of the cows. Portal-drained viscera net fluxes of ammonia-N and urea-N were in agreement with values reported earlier (Blouin et al., 2002; Raggio et al., 2004). However, extraction of PDV ammonia-N by the liver was lower in this trial (93%) than reported by Reynolds et al. (1988) and Blouin et al. (2002) (> 100%) but similar to hepatic removal of ammonia-N (94%) reported by De Visser et al. (1997) and Raggio et al. (2004). This resulted in a numerically positive absorption of ammonia-N (36 mmol/h) by the splanchnic tissue. However, hepatic-arterial differences were not different from zero. In the present study, the PDV removed 59% of the urea-N produced by the liver. This is higher than previously reported (Blouin et al., 2002; Raggio et al., 2004) and, again, could be related to the diet fed in this study. As mentioned previously, posttrial evaluation of the diet with the AminoCow (2004) model indicated that, considering the limited DM intake and the high level of milk production, this diet was marginally deficient in CP and RDP, a situation that should have led to more recycling of N through urea entry into the gut.
Glucose.
The addition of RPM had no effect on plasma concentrations or net fluxes of glucose across the splanchnic tissue and MG. Arterial concentrations and positive net PDV fluxes of glucose were in agreement with values reported by others (Weighart et al., 1986; Casse et al., 1994; Blouin et al., 2002), although again, portal-arterial differences were not different from zero. However, a number of studies have not found a net absorption of glucose through the PDV of lactating cows (De Visser et al., 1997; Reynolds et al., 1988; Berthiaume et al., 2001). Data with growing beef steers (Huntington et al., 1989) and heifers (Reynolds et al., 1991) suggest that dietary factors (amount and source of starch) are responsible for the differences between trials.
Net hepatic glucose production (2.38 kg/d) was sufficient to cover mammary glucose requirements (2.3 kg/d) estimated by dividing milk lactose yield (1.61 kg/d) by 0.7 (Elliot, 1976). Net mammary uptakes and mammary extractions of glucose were in close agreement with those reported in studies where incremental levels of Met were infused intragastrically (Guinard and Rulquin, 1995; Varvikko et al., 1999). In both cases, Met had no effect on glucose metabolism through the MG.
Pancreatic Hormones.
Circulating levels of insulin were similar to those reported in the literature (Casse et al., 1994; Guinard and Rulquin, 1995; Pisulewski et al., 1996; Blum et al., 1999). Duodenal infusions of Met had either no effect (Pisulewski et al., 1996) or elicited a quadratic increase (Guinard and Rulquin, 1995) in the circulating levels of insulin. The nonsignificant quadratic increase observed in the present trial would lend support to the latter. Liver, PDV, and TSP fluxes of insulin were slightly higher than fluxes reported with lactating dairy cows (Casse et al., 1994). Addition of RPM had no effect on circulating levels of glucagon, which were similar to those reported in steers fed at a high level of intake (Lapierre et al., 2000) but lower than values reported for dairy cows (Casse et al., 1994). It has been reported that infusion of supraphysiological levels of Met in sheep caused a significant increase in the concentrations of glucagon (Kuhara et al., 1991). This may indicate that the levels of RPM fed in the present trial were in the physiological range for high-producing dairy cows. The liver removed between 44 and 61% of insulin PDV flux and between 37 and 67% of glucagon PDV flux, lending support to the idea that the liver has a major impact on peripheral concentrations of pancreatic hormones (Reynolds et al., 1989; Lapierre et al., 2000). In any of the blood vessels sampled, RPM had no effect on insulin to glucagon ratio (data not shown). Although the interaction between parity and treatment was not significant, higher circulating levels and fluxes of insulin in primiparous cows (data not shown) indicate the difference in the endocrine status of the two groups of cows and should be kept in mind regarding the interpretation of the data.
| CONCLUSIONS |
|---|
|
|
|---|
|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Received for publication February 25, 2005. Accepted for publication November 28, 2005.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. B. Hall and G. B. Huntington Nutrient synchrony: Sound in theory, elusive in practice J Anim Sci, April 1, 2008; 86(14_suppl): E287 - E292. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Broderick, M. J. Stevenson, R. A. Patton, N. E. Lobos, and J. J. Olmos Colmenero Effect of Supplementing Rumen-Protected Methionine on Production and Nitrogen Excretion in Lactating Dairy Cows J Dairy Sci, March 1, 2008; 91(3): 1092 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Doepel, G. E. Lobley, J. F. Bernier, P. Dubreuil, and H. Lapierre Effect of Glutamine Supplementation on Splanchnic Metabolism in Lactating Dairy Cows J Dairy Sci, September 1, 2007; 90(9): 4325 - 4333. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pacheco, C. G. Schwab, R. Berthiaume, G. Raggio, and H. Lapierre Comparison of Net Portal Absorption with Predicted Flow of Digestible Amino Acids: Scope for Improving Current Models? J Dairy Sci, December 1, 2006; 89(12): 4747 - 4757. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||